Cargando…

Diagnostics and Therapeutics in Early Stage Breast Cancer Receiving Neoadjuvant Systemic Therapy

Detalles Bibliográficos
Autores principales:	Belli, Paolo, Palma, Simone, Costantini, Melania
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571562/ https://www.ncbi.nlm.nih.gov/pubmed/37835568 http://dx.doi.org/10.3390/cancers15194874

Ejemplares similares

Neoadjuvant immunotherapy in early-stage triple negative breast cancer
por: Laouris, Panayiotis, et al.
Publicado: (2023)

Staging Breast Cancer with MRI, the T. A Key Role in the Neoadjuvant Setting
por: Panico, Camilla, et al.
Publicado: (2022)

Approaching Neoadjuvant Therapy in the Management of Early-Stage Breast Cancer
por: Hyder, Tara, et al.
Publicado: (2021)

Neoadjuvant therapy for early-stage breast cancer: the clinical utility of pertuzumab
por: Gollamudi, Jahnavi, et al.
Publicado: (2016)

Cytokines, Fatigue, and Cutaneous Erythema in Early Stage Breast Cancer Patients Receiving Adjuvant Radiation Therapy
por: De Sanctis, Vitaliana, et al.
Publicado: (2014)

Early onset lactating adenoma and the role of breast MRI: a case report
por: Magno, Stefano, et al.
Publicado: (2009)

Racial Disparities in Pathological Complete Response Among Patients Receiving Neoadjuvant Chemotherapy for Early-Stage Breast Cancer
por: Zhao, Fangyuan, et al.
Publicado: (2023)

Current trends in diagnostic and therapeutic management of the axilla in breast cancer patients receiving neoadjuvant therapy: results of the German-wide NOGGO MONITOR 24 survey
por: Banys-Paluchowski, Maggie, et al.
Publicado: (2022)

Staging NAFLD: Diagnostic and Therapeutic Value of TAM Signaling
por: Cubero, Francisco Javier
Publicado: (2019)

Examination of Tumor Regression Grading Systems in Breast Cancer Patients Who Received Neoadjuvant Therapy
por: Sejben, Anita, et al.
Publicado: (2020)

Neoadjuvant treatment for male breast cancer
por: Fentiman, Ian Stuart
Publicado: (2023)

Neoadjuvant endocrine therapy use in early stage breast cancer during the covid-19 pandemic
por: Park, Ko Un, et al.
Publicado: (2021)

Neoadjuvant systemic therapy for breast cancer
por: Zaborowski, Alexandra M, et al.
Publicado: (2023)

Characterization of circulating tumor cells in early breast cancer patients receiving neoadjuvant chemotherapy
por: Jakabova, Anna, et al.
Publicado: (2021)

Diagnostics Receives First Impact Factor
por: Kjaer, Andreas
Publicado: (2019)

Surgical Planning after Neoadjuvant Treatment in Breast Cancer: A Multimodality Imaging-Based Approach Focused on MRI
por: Conti, Marco, et al.
Publicado: (2023)

Impact of Hyperglycemia on Outcomes among Patients Receiving Neoadjuvant Chemotherapy for Bulky Early Stage Cervical Cancer
por: Li, Jing, et al.
Publicado: (2016)

Radiological assessment of neoadjuvant chemotherapy in breast cancer
por: Ollivier, Liliane
Publicado: (2015)

Neoadjuvant treatment: the future of patients with breast cancer
por: Reyal, F, et al.
Publicado: (2018)

Neoadjuvant therapy for resectable pancreatic cancers
por: Inoue, Yosuke, et al.
Publicado: (2022)

Predictive Role of Leptin Receptor (Ob-R) Overexpression in Patients with Early Breast Cancer Receiving Neoadjuvant Systemic Treatment
por: García-Estévez, Laura, et al.
Publicado: (2021)

Predicting the response to neoadjuvant therapy for early-stage breast cancer: tumor-, blood-, and imaging-related biomarkers
por: Tan, Wenyong, et al.
Publicado: (2018)

Effect of pathologic stages on postmastectomy radiation therapy in breast cancer receiving neoadjuvant chemotherapy and total mastectomy: A Cancer Database Analysis
por: Zhang, Jiaqiang, et al.
Publicado: (2020)

Evaluating the eighth edition TNM staging system for esophageal cancer among patients receiving neoadjuvant therapy: A SEER study
por: Yuan, Yonggang, et al.
Publicado: (2020)

Pathology of Breast Carcinoma: Diagnostic, Prognostic, and Therapeutic Issues and Challenges
por: Bhargava, Rohit, et al.
Publicado: (2011)

Diagnostic Accuracy of MRI in Evaluating Response After Neoadjuvant Systemic Therapy in Operable Breast Cancer
por: Khazindar, Abdullah R, et al.
Publicado: (2021)

Pathologic stage dictates survival after neoadjuvant radiation for rectal cancer
por: Delitto, Daniel, et al.
Publicado: (2018)

The impact of driver mutation on the treatment outcome of early-stage lung cancer patients receiving neoadjuvant immunotherapy and chemotherapy
por: Su, Po-Lan, et al.
Publicado: (2022)

Neoadjuvant approach in patients with early breast cancer: patient assessment, staging, and planning()
por: Rubio, Isabel T., et al.
Publicado: (2021)

Current treatment of early breast cancer: adjuvant and neoadjuvant therapy
por: Miller, Elizabeth, et al.
Publicado: (2014)

Inflammatory Blood Markers as Prognostic and Predictive Factors in Early Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
por: Corbeau, Ileana, et al.
Publicado: (2020)

Circulating Tumor DNA Predicts the Response and Prognosis in Patients With Early Breast Cancer Receiving Neoadjuvant Chemotherapy
por: Li, Shunying, et al.
Publicado: (2020)

Neoadjuvant Systemic Therapy in Early Breast Cancer: Results of a Prospective Observational Multicenter BRIDE Study
por: Gori, Stefania, et al.
Publicado: (2023)

Cognitive function among women with breast cancer receiving endocrine therapy: what are the impacts?
por: Fardell, Joanna E, et al.
Publicado: (2023)

Neoadjuvant treatment of HER2-positive breast cancer: should therapy differ based on hormone receptor status?
por: Harbeck, Nadia
Publicado: (2018)

Outcome for triple negative breast cancer in a retrospective cohort with an emphasis on response to platinum-based neoadjuvant therapy
por: Walsh, Elaine M., et al.
Publicado: (2018)

Special Issue “Current Management of Early and Advanced Rectal Cancer”
por: Belli, Filiberto
Publicado: (2023)

Is Neoadjuvant Therapy Needed in Patients with Resectable Pancreatic Cancer?
por: Kim, Dong Uk
Publicado: (2022)

Neoadjuvant radiotherapy of early-stage breast cancer and long-term disease-free survival
por: Poleszczuk, Jan, et al.
Publicado: (2017)

The Dual Blockade in the Neoadjuvant Setting of HER-2 Positive Early-Stage Breast Cancer
por: Pop, Lucian, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1dnmui848vvbqhr56g9r6vlo83